BAFNA PHARMACEUTICALS
Smallcap | BSE
Sector
Here's the live share price of Bafna Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
1.99₹ 9.15
As on Oct 16, 2026, 04:01 PM IST
Source: Dion Global
Bafna Pharmaceuticals Price Performance
Today's LowToday's High
₹460.00₹468.65
₹468.65
52 Weeks' Low52 Weeks' High
₹95.00₹468.65
₹468.65
Open Price
₹465.00
Prev. Close
₹459.50
Volume
72,951
Source: Dion Global
Bafna Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Bafna Pharmaceuticals | 10.27 | 51.18 | 108.66 | 262.59 | 203.04 | 74.87 | 27.82 |
| Sun Pharmaceutical Industries | 0.18 | -5.04 | -9.74 | 3.95 | 6.04 | 15.75 | 16.08 |
| Divi's Laboratories | -1.14 | 0.22 | 25.96 | 46.41 | 39.74 | 36.09 | 11.54 |
| Torrent Pharmaceuticals | -2.15 | -5.45 | -8.85 | 9.71 | 29.05 | 33.62 | 24.00 |
| Zydus Lifesciences | 0.83 | 1.75 | -2.53 | 19.71 | 14.26 | 23.96 | 16.03 |
| Laurus Labs | 1.32 | 8.03 | 32.19 | 82.28 | 135.84 | 72.87 | 26.12 |
| Cipla | 1.67 | -2.56 | -7.31 | 7.66 | -15.53 | 4.40 | 7.95 |
| Dr. Reddy's Laboratories | 3.08 | 7.56 | 0.65 | 0.87 | -0.66 | 3.91 | 4.79 |
| Aurobindo Pharma | -1.63 | 1.08 | 7.14 | 19.66 | 50.00 | 22.19 | 18.22 |
| Mankind Pharma | -3.97 | 1.20 | -10.61 | 8.09 | -7.32 | 7.81 | 9.82 |
| Lupin | -0.21 | -4.46 | -21.77 | -15.93 | 0.27 | 17.74 | 15.86 |
| Glenmark Pharmaceuticals | -2.94 | -7.63 | -2.78 | -1.14 | 19.23 | 40.76 | 33.75 |
| Alkem Laboratories | -4.00 | -2.59 | -11.38 | -9.22 | -8.48 | 11.88 | 5.53 |
| Biocon | 0.43 | -6.43 | -20.58 | -0.16 | -2.26 | 11.26 | 0.43 |
| Abbott India | 0.77 | 0.31 | -6.03 | 1.31 | -12.19 | 5.26 | 4.12 |
| Gland Pharma | -0.61 | 7.57 | 20.15 | 75.32 | 58.52 | 24.56 | -4.10 |
| Ipca Laboratories | -3.70 | -5.38 | -2.45 | 26.26 | 43.26 | 24.18 | 8.86 |
| Anthem Biosciences | -4.57 | -9.54 | 8.32 | 13.73 | 6.44 | 4.02 | 2.39 |
| GlaxoSmithKline Pharmaceuticals | 1.08 | -10.04 | 2.42 | 6.12 | -5.91 | 18.58 | 11.73 |
| Ajanta Pharma | -2.70 | -5.19 | -3.75 | 17.36 | 34.14 | 23.67 | 17.62 |
Source: Dion Global
Over the last one year, Bafna Pharmaceuticals has gained 203.04% compared to peers like Sun Pharmaceutical Industries (6.04%), Divi's Laboratories (39.74%), Torrent Pharmaceuticals (29.05%). From a 5 year perspective, Bafna Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (16.08%) and Divi's Laboratories (11.54%).
Bafna Pharmaceuticals Financials
Source: Dion Global
Bafna Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 433.66 | 433.99 |
| 10 | 413.28 | 414.88 |
| 20 | 376.32 | 385.06 |
| 50 | 320.19 | 330.74 |
| 100 | 258.77 | 277.73 |
| 200 | 193.63 | 222.65 |
Source: Dion Global
Bafna Pharmaceuticals Share Holding Pattern
In the latest quarter, Bafna Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 9.34%, and public shareholding unchanged at 15.66% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Bafna Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 12, 2026, 10:27 PM IST IST | Bafna Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 11, 2026, 11:44 PM IST IST | Bafna Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 11, 2026, 08:34 PM IST IST | Bafna Pharma. - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Aug 20, 2026, 02:35 AM IST IST | Bafna Pharma. - Notice Of 31St Annual General Meeting Of The Company For The F.Y 2025-2026 |
| Aug 20, 2026, 02:29 AM IST IST | Bafna Pharma. - Reg. 34 (1) Annual Report. |
Source: Dion Global
About Bafna Pharmaceuticals
Bafna Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 28/03/1995 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24294TN1995PLC030698 and registration number is 030698. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 150.62 Cr. and Equity Capital is Rs. 23.66 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- AddressBafna Towers, New�No.�68,�Old�No. 299, Chennai (Madras) Tamil Nadu 600001
- Contact
Source: Dion Global
Management
- Mr. Vinayak Dinesh DendukuriWhole Time Director
- Mrs. S HemalathaWhole Time Director
- Mr. Upendar Mekala ReddyNon Exe.Non Ind.Director
- Mrs. Akila C RajuNon Exe.Non Ind.Director
- Mr. P K SundaresanInd. Non-Executive Director
- Ms. Ravichandran ChitraInd. Non-Executive Director
FAQs on Bafna Pharmaceuticals Share Price
What is the share price of Bafna Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Bafna Pharmaceuticals is ₹468.65 as on Oct 16, 2026.
What kind of stock is Bafna Pharmaceuticals?
The Bafna Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Bafna Pharmaceuticals?
The market cap of Bafna Pharmaceuticals is ₹1,108.65 Cr as on Oct 16, 2026.
What are today's High and Low prices of Bafna Pharmaceuticals?
Today’s highest and lowest price of Bafna Pharmaceuticals are ₹468.65 and ₹460.00.
What are the 52 Week High and 52 Week Low of Bafna Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Bafna Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Bafna Pharmaceuticals is ₹468.65 and 52-week low of Bafna Pharmaceuticals is ₹95.00 as on Oct 16, 2026.
How has the Bafna Pharmaceuticals performed historically in terms of returns?
The Bafna Pharmaceuticals has shown returns of 1.99% over the past day, 51.18% for the past month, 108.66% over 3 months, 203.04% over 1 year, 74.87% across 3 years, and 27.82% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Bafna Pharmaceuticals?
P/E ratio of and PB ratio of Bafna Pharmaceuticals are -44.83 and 65.03 on Oct 16, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global
✕